Literature DB >> 11519721

Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats.

M N Lipovac, A Hashim, H Sershen, D Allen, T Cooper, P Czobor, A Lajtha.   

Abstract

Studies have shown a greater preference for the self-administration of drugs such as nicotine and cocaine in the Lewis rat strain than in the Fischer 344 strain. We examined some factors that could contribute to such a difference. The baseline level of extracellular dopamine in nucleus accumbens shell was about 3-times higher in Fischer rats than in Lewis rats (3.18 +/- 0.26 vs. 1.09 +/- 0.14 pg/ sample). Nicotine (50-100 microg/kg)-induced release of dopamine, expressed in absolute terms, was similar in the two strains. Dopamine release expressed in relative terms (as percent of baseline), however, was significantly greater in Lewis rats than in Fischer rats at 30 min after the first nicotine injection. We suggest that the relative increase is of more influence than the absolute level for determining preference; a lower physiological extracellular dopamine level thus represent a risk factor for increased preference. Amphetamine-induced dopamine release expressed in relative terms was not greater in the Lewis strain. In the initial time period of the microdialysis experiments, a sharper peak in nicotine-induced accumbal dopamine release in Lewis and a less but more sustained release in Fischer rats was observed. This release pattern paralleled the faster clearance of nicotine from blood of Lewis compared to Fischer rats. In tissue slices the electrically induced dopamine release was highest in the nucleus accumbens and lowest in the ventral tegmentum. A significant effect of nicotine was lowering the electrically induced release of dopamine in frontal cortex slices from Fischer brain and increasing this dopamine release in the ventral tegmentum of Lewis brain slices indicating that the ventral tegmentum, an area controlling dopamine release in the accumbens, is more responsive to nicotine in the Lewis rat. Nicotine levels tended to be more sustained in Fischer rats in different brain regions, although the difference in nicotine levels between the strains was not significant at any time period. Several factors contribute to nicotine preference, including the endogenous dopamine level, and the sensitivity of ventral tegmentum neurons to nicotine-induced dopamine release. Strain differences in pharmacokinetics of nicotine may also play a role.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519721     DOI: 10.1023/a:1010979018217

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

1.  Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons.

Authors:  C K Meshul; J F McGinty
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.

Authors:  G Lucas; U Spampinato
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

3.  Progress towards the development of animal models of smoking-related behaviors.

Authors:  A C Collins; M J Marks
Journal:  J Addict Dis       Date:  1991

4.  Striatal application of nicotine, but not of lobeline, attenuates dopamine release in freely moving rats.

Authors:  D Lecca; I Shim; E Costa; J I Javaid
Journal:  Neuropharmacology       Date:  2000       Impact factor: 5.250

5.  Strain differences in mesotelencephalic dopaminergic neuronal regulation between Fischer 344 and Lewis rats.

Authors:  S E Lindley; T G Bengoechea; D L Wong; A F Schatzberg
Journal:  Brain Res       Date:  1999-06-19       Impact factor: 3.252

6.  Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels.

Authors:  G Flores; G K Wood; D Barbeau; R Quirion; L K Srivastava
Journal:  Brain Res       Date:  1998-12-14       Impact factor: 3.252

7.  Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors.

Authors:  A C Collins; C B Evans; L L Miner; M J Marks
Journal:  Pharmacol Biochem Behav       Date:  1986-06       Impact factor: 3.533

8.  Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area.

Authors:  D Beitner-Johnson; X Guitart; E J Nestler
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

9.  Extracellular dopamine and its metabolites in the nucleus accumbens of Fischer and Lewis rats: basal levels and cocaine-induced changes.

Authors:  R E Strecker; W F Eberle; C R Ashby
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals.

Authors:  X Guitart; J H Kogan; M Berhow; R Z Terwilliger; G K Aghajanian; E J Nestler
Journal:  Brain Res       Date:  1993-05-14       Impact factor: 3.252

View more
  23 in total

1.  Effects of clomipramine on self-control choice in Lewis and Fischer 344 rats.

Authors:  Karen G Anderson; William L Woolverton
Journal:  Pharmacol Biochem Behav       Date:  2005-01-18       Impact factor: 3.533

2.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; David Scheibal; Emily Hahn; Sharon Shiraga; Eleanor Zamora-Paja; Judah Farahi; Sanjaya Saxena; Edythe D London; James T McCracken
Journal:  Arch Gen Psychiatry       Date:  2006-07

3.  A long-term study of the impulsive choices of Lewis and Fischer 344 rats.

Authors:  Carlos F Aparicio; Mirari Elcoro; Benigno Alonso-Alvarez
Journal:  Learn Behav       Date:  2015-09       Impact factor: 1.986

4.  Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.

Authors:  Arthur L Brody; Mark A Mandelkern; Edythe D London; Richard E Olmstead; Judah Farahi; David Scheibal; Jennifer Jou; Valerie Allen; Emmanuelle Tiongson; Svetlana I Chefer; Andrei O Koren; Alexey G Mukhin
Journal:  Arch Gen Psychiatry       Date:  2006-08

5.  Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence.

Authors:  Arthur L Brody; Edythe D London; Richard E Olmstead; Zoe Allen-Martinez; Stephanie Shulenberger; Matthew R Costello; Anna L Abrams; David Scheibal; Judah Farahi; Steven Shoptaw; Mark A Mandelkern
Journal:  Psychiatry Res       Date:  2010-08-03       Impact factor: 3.222

6.  Regional heterogeneity of nicotine effects on neurotransmitters in rat brains in vivo at low doses.

Authors:  S Rossi; S Singer; E Shearman; H Sershen; A Lajtha
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

Review 7.  Heterogeneity of reward mechanisms.

Authors:  A Lajtha; H Sershen
Journal:  Neurochem Res       Date:  2009-12-12       Impact factor: 3.996

8.  Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; Zoe Allen-Martinez; David Scheibal; Anna L Abrams; Matthew R Costello; Judah Farahi; Sanjaya Saxena; John Monterosso; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2008-06-18       Impact factor: 7.853

Review 9.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function.

Authors:  S Singer; S Rossi; S Verzosa; A Hashim; R Lonow; T Cooper; H Sershen; A Lajtha
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.